Skip to content

Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device

Evaluation of Clinical Utility of Non-invasive Hemodynamic Monitoring Device (HemoVista™) in the Clinical Filed

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05996965
Enrollment
40
Registered
2023-08-18
Start date
2023-11-21
Completion date
2024-12-30
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Complication

Brief summary

In patients undergoing surgery under general anesthesia, the clinical utility of non-invasive hemodynamic status monitoring equipment using HemoVista is compared with invasive hemodynamic status monitoring equipment FloTrac.

Detailed description

For patients who are scheduled to monitor invasive blood pressure, invasive hemodynamic monitoring using FloTrac and additional HemoVista sensors are attached and output data are obtained at the same time during general anesthesia. FloTrac is used to conduct conventional anesthesia and fluid therapy, and the accuracy of HemoVista, a non-invasive hemodynamic monitoring equipment, is compared through prospective observational studies.

Interventions

OTHERHemoVista

additional attatchment of non-invasive hemodynamic monitoring HemoVista with FloTrac

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients aged 20 or older who undergo surgery under general anesthesia for more than two hours * invasive close hemodynamic monitoring with FloTrac is needed

Exclusion criteria

* problems in site where HemoVista is attached

Design outcomes

Primary

MeasureTime frameDescription
degree of agreement in cardiac outputduring surgerydegree of agreement in cardiac output between HemoVista and FloTrac

Countries

South Korea

Contacts

Primary ContactHee-Soo Kim
dami0605@snu.ac.kr+82220723659

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026